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Selenium-containing heterocycles from
isoselenocyanates:5-methylselenazole derivatives from the
reaction with malononitrile and propargyl chloride
Abstract
Aryl isoselenocyanates 1 react with malononitrile (6a) and propargylchloride (8) in DMF in the presence
of Et3N to give the corresponding
2-(3-aryl-2,3-dihydro-4-methyl-1,3-selenazol-2-ylidene)malononitriles 12 as major products. The
analogous reaction takes place with benzoylacetonitrile (6b) instead of 6a. In some cases, the
corresponding non-cyclic 2-[(arylamino)(prop-2-ynylselanyl)methylidene]malononitriles 9 were
obtained as minor products. The structures of 9e and 11a have been established by X-ray
crystallography.
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2Aryl isoselenocyanates 1 react with malononitrile (6a) and propargylchloride (8) in
DMF in the presence of Et3N to give the corresponding 2-(3-aryl-2,3-dihydro-4-methyl-1,3-
selenazol-2-ylidene)malononitriles 12 as major products. The analogous reaction takes place
with benzoylacetonitrile (6b) instead of 6a. In some cases, the corresponding non-cyclic 2-
[(arylamino)(prop-2-ynylselanyl)methylidene]malononitriles 9 were obtained as minor
products. The structures of 9e and 11a have been established by X-ray crystallography.
31. Introduction. – The unique biochemical and pharmaceutical properties of
organoselenium compounds make them very attractive, in particular for bioorganic and
medicinal chemists. This type of compounds, especially selenium-containing heterocycles,
has gradually gained importance over the last twenty-five years. Among the different possible
heterocyclic systems are not least the 1,3-selenazoles. These heterocycles show remarkable
reactivities and chemical properties and also find diverse pharmaceutical applications. Several
reviews [1] describe their preparation [2] and pharmaceutical potential [3]. They have been
studied widely, for example as anticancer [4] and antiradiation agents [5], as protein kinase
activators [6] and as superoxide anion-scavengers [7], but they are also well recognized in dye
chemistry [8] and with respect to their physical properties [9].
Because of this broad interest, we have focused our attention on the use of
isoselenocyanates 1 as building blocks for the preparation of selenaheterocycles, in particular
1,3-selenazole derivatives. Isoselenocyanates have proved to be useful starting materials,
since they are easy to prepare, safe to handle and to store. In addition, they typically react
under mild conditions, which are compatible with the low stability of substrates and products
in the preparation of complex molecules [10].
It has been shown that the reactions of bifunctional nucleophiles 2 with 1 yield five to
seven-membered heterocycles of type 4 and 5 [10c][11–16] (Scheme 1). The proposed
reaction mechanism involves the formation of the adduct 3, which undergoes ring closure by
nucleophilic substitution of the leaving group X either by the Se or the N-atom. Analogously,
three-component reactions of 1 with a nucleophile and a bis-electrophile were carried out to
yield selenaheterocycles [10c][17–20]. As a continuation of this work, we decided to
investigate the addition of C-nucleophiles with 1 and to trap the intermediate by a suitably
substituted electrophilic reagent, i.e., propargyl chloride.
4Scheme 1
Several syntheses of heterocycles by using propargyl derivatives as acetylenic building
blocks are described in the literature. For example, propargyl bromides were used for the
preparation of fused bicyclic systems like selenazolo[2,3-c][1,2,4]triazines [21] and
thiazolo[2,3-c][1,2,4]triazines [22], and thieno-[3,2-d]-pyrimidin-4-ones were prepared via a
thio-Claisen rearrangement of 5-(propargylsulfanyl)pyrimidin-4(3H)-ones [23]. The reactions
of isocyanates with propargyl amine and propargyl alcohol led to 4-methylidenimidazolidin-
2-ones and -1,3-oxazolidin-2-ones, respectively [24], whereas isothiocyanates and 3-
methylbut-1-yn-3-ol by treatment with NaH yielded 4-methylidene-5,5-dimethyl-1,3-
oxazolidine-2-thiones [25]. Whereas, in these cases, the ring closure of the intermediate
occurs via nucleophilic attack of the N-atom at the inner C-atom of the acetylene unit, the
reaction of isoselenocyanates and propargyl amines gave 2-amino-4,5-dihydro-5-
methylidene-1,3-selenazoles by a cyclization via the Se-atom [26].
As a part of our program aiming at the development of simple procedures for the
preparation of selenium-containing heterocycles [10c][11-20][27], we report here on a novel
and efficient synthesis of 5-methyl-1,3-selenazole derivatives.
2. Results and Discussion. – The carbanion generated from ethyl α-cyanomethylene
derivatives 6 and Et3N in DMF reacts with aromatic isoselenocyanates 1 to give intermediate
ketene-N,Se-hemiacetals of type 7. It was expected that the latter react with propargyl chloride
by substitution of Cl– to give 9. Subsequent ring closure via nucleophilic addition of the N-
atom at the acetylene group could lead to selenazolidine derivatives of type 11 (Scheme 2).
5Alternatively, a base-catalyzed isomerization of 9 to give the allenyl derivative 10, which also
could be formed via a SN2’ reaction of 7 with 8, followed by cyclization to give 11 could be
conceivable. Similar ring closure reactions, which lead to 1,3-thiazole derivatives, were
described by Junjappa and coworkers [28] and later by Suma et al. [29].
Scheme 2
The necessary isoselenocyanates 1 were prepared easily by a slightly modified Barton
procedure [30] from the corresponding N-arylformamides by treatment with COCl2 and
elemental selenium. An equimolar mixture of malononitrile 6a, phenyl isoselenocyanate 1a,
Et3N and propargyl chloride in DMF was stirred at room temperature for 4 h. Then, the
solvent was evaporated under reduced pressure, the solid residue was separated by column
chromatography on SiO2, and recrystallization of the major product from AcOEt gave 2-(2,3-
dihydro-4-methyl-3-phenyl-1,3-selenazol-2-ylidene)malononitrile (12a) in 50% yield
(Scheme 3, Table 1).
Scheme 3
Table 1. Preparation of Selenazole Derivatives 12 from Isoselenocyanates 1
The structure of 12a has been deduced from the spectroscopic data and elemental
analysis. Most indicative are the NMR spectra, which show signals for a Me group (1H: 1.84
ppm, 13C:  16.8 ppm) and for =CH– (1H: 6.78 ppm, 13C: 102.8 ppm). The 13C signals for the
malononitrile moiety (C(CN)2 at 48.2 ppm) and SeC(2)N of the five-membered heterocycle
(174.0 ppm) are characteristic for this structure (see [17][18[]20]).
6Single crystals of 12a, which were suitable for an X-ray crystal-structure determination,
were grown from AcOEt.  Surprisingly, the structure in the crystal is the 4-methylidene
derivative 11a, i.e., an isomer of 12a (Fig. 1).
Figure 1. ORTEP Plot [31] of the molecular structure of 11a (arbitrary numbering of
atoms; 50% probability ellipsoids)
The molecule 11a sits on a crystallographic mirror plane and is partly disordered about
this plane. The heterocyclic ring is not planar with the methylidene group within the ring
being puckered out of the ring plane to form an envelope conformation. The mirror symmetry
requires that this atom is disordered to both sides of the mirror plane. The terminal
methylidene group also lies out of the plane, so is similarly disordered across both sides of the
mirror plane. The Ph ring lies perpendicular to the mirror plane and is also tilted so that the
ipso and para C-atoms do not lie on the mirror, which results in the entire phenyl ring being
disordered about the mirror plane as well. The geometric parameters of 11a are very similar to
those of analogous 2-(1,3-selenazolidin- and 1,3-selenazinan-2-ylidene)malononitriles
described in [17][18][20], i.e., the C(2),C(6) bond is longer (1.389(3) Å) than a normal C=C
bond, the formal single bonds  Se(1)–C(2), N(3)–C(2), C(6)–C(7), and C(6)–C(8) are short
(1.883(2), 1.344(3), 1.422(4), and 1.425(4) Å, resp.), and the bond angle C(2)–C(6)–C(7) is
widend (127.6(2)°), whereas the angles C(2)–C(6)–C(8) and C(7)–C(6)–C(8) are compressed
(116.8(2)° and 115.6(2)°, resp.), with respect to the normally expected angles of 120°. These
parameters indicate significant electron delocalization within the molecule.
The analogous reactions of 4-methoxyphenyl- (1b), 4-chlorophenyl- (1c ), 4-
bromophenyl- (1d), and 4-methylphenyl isoselenocyanate (1e) with 6a and 8 yielded the
7correspondingly substituted products 12b–12e (Table 1). In the cases of 1b and 1d, the
proposed intermediates, i.e., the non-cyclic ketene-N,Se-hemiacetals 9b and 9e, respectively
(Scheme 2, Table 1), were obtained as minor products after chromatographic workup. The
cyclization to give the corresponding selenazolidine derivatives 12b and 12e has been
achieved quantitatively by treatment with a stronger base like NaH.
The elucidation of the structures of 9a and 9e was based again on the analytical and
spectroscopic data compared with those for similar compounds (cf. [20]). Finally, the
structure of 9d was established by X-ray crystallography (Fig. 2).
Figure 2. ORTEP Plot [31] of the molecular structure of 9e (arbitrary numbering of
atoms; 50% probability ellipsoids)
The environment about the C(1)=C(2) bond is not planar with the plane defined by C(2),
C(6) and C(7) making an angle of 14.2(2)° with the plane defined by N(1), C(1) and the Se-
atom.  Again, the C(1),C(2) bond is relatively long (1.390(2) Å), and the single bonds
Se–C(1), N(1)–C(1), C(2)–C(6), and C(2)–C(7) are relatively short (1.907(2), 1.335(2),
1.418(2), and 1.430(2) Å, resp.). The NH group forms an intermolecular H-bond with one of
the cyano N-atoms of a neighboring molecule and thereby links the molecules into extended
chains which run parallel to the [001] direction and have a graph set motif [32] of C(6).
Similar to malononitrile (6a), the base-catalyzed reaction of benzoylacetonitrile (6b),
phenyl isoselenocyanate (1a), and propargyl chloride (8) yielded a 1,3-selenazole derivative
of type 12, i.e., the 3-oxo-3-phenyl-2-(2,3-dihydro-1,3-selenazol-2-ylidene)propionitrile 12f
(Table 1). The NMR spectra proved again the structure of the 2,3-dihydro-4-methyl-1,3-
selenazole moiety, with 1H- and 13C-absorptions of the Me group at 1.95 and 16.9 ppm,
8respectively, and signals for H-C(5) at 7.02 and 109.8 ppm. The main differences to the
spectra of 12a–12e are the presence of only one C≡N absorption (117.5 ppm) and a C=O
signal at 187.7 ppm.
In conclusion, we have evidenced that the base catalyzed three-component reaction with
α-cyanomethylene derivatives 6, isoselenocyanates 1, and propargyl chloride (8) offers a
convenient access to 1,3-selenazole derivatives of type 12. This is of special importance,
because the attempted preparation of those derivatives in the reaction with 1, 6, and α-
bromoketones failed [20]. As proposed in Scheme 2, the reaction proceeds via addition of the
carbanion of 6 onto the isoselenocyanate 1 to yield the acyclic intermediate 7, which then
reacts with 8 via the Se-atom to give the ketene-N,Se-hemiacetal 9. This intermediate, which
has been isolated in some cases, undergoes a base-catalyzed cyclization to lead, finally, to the
products 12. As described for several cyclization reactions with acetylenic compounds (see,
e.g., refs. [21–25]), the ring closure of 9 occurs in a 5-exo-dig fashion [33] to give the
methylidene derivative 11, the structure of which could be proven by X-ray crystallography.
The isomeric product 12 is then formed via a H-shift.
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Experimental Part
91. General. See [27a,b]. TLC: silica gel 60 F254 plates (0.25 mm; Merck). Column
chromatography (CC): silica gel 60 (0.040-0.063 mm; Merck). M.p.: Büchi B-540 apparatus
in capillaries; uncorrected. 1H-NMR (300 MHz) and 13C-NMR (75.5 MHz) spectra: Bruker
ARX-300 instrument, in CDCl3; chemical shifts in ppm. CI-MS: Finnigan SSQ-700 or MAT-
90 instrument; NH3 or i-butane as carrier gas.
2. Starting Materials. Propanedinitrile (= malononitrile, 6a), benzoylacetonitrile (6b),
and propargyl chloride are commercially available (Fluka). Isoselenocyanates 1 were
prepared according to Barton’s procedure starting from formamides [30]. Formanilide is
commercially  available (Fluka), N-(4-chlorophenyl)-, N-(4-bromophenyl)-, and N-(4-
methoxyphenyl)-, and N-(4-methylphenyl)formamide were prepared from the respective
aniline and 95% formic acid [34] (see also [19]).
3. General Procedure for the Preparation of 2,3-Dihydro-4-methyl-1,3-selenazole
Derivatives 12a–12f. A 50 ml round-bottom flask equipped with magnetic stirrer and
condenser was charged with a soln. of 6a or 6b (1.10 mmol) in DMF (25 ml). Then, Et3N
(0.15 ml, 1.10 mmol) was added, the mixture was stirred for 45 min at r.t., and
isoselenocyanate (1, 1.10 mmol) was added. After stirring for 30 min at r.t., propargyl
chloride (8, 0.08 ml, 1.10 mmol) was added, the mixture was stirred for 4 h at r.t., and then
evaporated to dryness under reduced pressure. The crude product was purified by CC (SiO2,
hexane/AcOEt 100:0 to 1:1) and crystallized from AcOEt.
2-(2,3-Dihydro-4-methyl-3-phenyl-1,3-selenazol-2-ylidene)malononitrile (12a. Yield:
158.8 mg (50%). Yellowish crystals. M.p. 235–237°. IR (KBr): 3127w, 2925w, 2198s, 2185s,
1641w, 1595w, 1523s, 1493s, 1423w, 1363m, 1271m, 844w, 762w, 695m. IR (Nujol): 3022w,
2942m, 2916m, 2881m, 2842s, 2725w, 2197s, 2185s, 1639m, 1593m, 1523m, 1462s, 1377s,
1365m, 1270m, 1189w, 1160w, 1072w, 1028w, 1012w, 910w, 864w, 844m, 828w, 812w,
10
762m, 736m, 694m, 638w, 624w, 611w. 1H-NMR: 1.84 (s, Me); 6.78 (s, HC(5’)); 7.30 (d, J =
8.1, 2 arom. H); 7.55–7.64 (m , 3 arom. H). 13C-NMR: 16.8 (Me); 48.2 (C(CN)2); 102.8
(C(5’)); 112.5, 118.7 (2 CN); 128.7 (2 arom. CH); 130.2 (2 arom. CH); 131.5 (1 arom. CH);
136.0 (C(4’)); 141.1 (1 arom. C); 174.0 (C(2’)). CI-MS (NH3): 592 (6), 590 (5, [2M+NH4]
+),
307 (19), 306 (16), 305 (100, [M(80Se)+NH4]
+), 304 (8), 303 (51), 302 (19), 301 (19), 288 (7,
[M(80Se)+1]+). Anal. calc. for C13H9N3Se (286.19): C 54.46, H 3.17, N 14.68; found: C 54.46,
H 3.24, N 14.78.
Suitable crystals for the X-ray crystal structure determination were grown from AcOEt
by slow evaporation of the solvent. These crystals proved to be 2-(4-methylidene-3-phenyl-
1,3-selenazolidin-2-ylidene)malononitrile (11a).
2-[2,3-Dihydro-3-(4-methoxyphenyl)-4-methyl-1,3-selenazol-2-ylidene]malononitrile
(12b). Yield: 156.5 mg (45%). Yellowish crystals. M.p. 247–249°. IR (KBr): 3116w, 2197s,
2181s, 1638w, 1604w, 1587w, 1510s, 1486s, 1465m, 1389w, 1366w, 1350w, 1299m, 1256s,
1171m, 1107w, 1020m, 873w, 844m, 773w, 754w, 736w, 718w, 615w, 602w. 1H-NMR: 1.88
(s, Me); 3.93 (s, MeO); 6.82 (s, HC(5’)); 7.09, 7.25 (AA’BB’, JAB = 8.2, 4 arom. H). 
13C-
NMR: 16.8 (Me); 48.2 (C(CN)2); 55.5 (MeO); 102.4 (C(5’)); 112.8, 118.9 (2 CN); 115.2 (2
arom. CH); 128.5 (C(4’)); 129.8 (2 arom. CH); 141.6, 161.6 (2 arom. C); 174.5 (C(2’)). CI-
MS (i-butane): 320 (19), 319 (16), 318 (100, [M(80Se)+1]+), 317 (18), 316 (52), 315 (23), 314
(21). Anal. calc. for C14H11N3OSe (316.22): C 53.18, H 3.51, N 13.29; found: C 53.29, H
3.65, N 13.16.
2-[2,3-Dihydro-3-(4-chlorophenyl)-4-methyl-1,3-selenazol-2-ylidene]malononitrile
(12c). Yield: 158.7 mg (45%). Yellowish crystals. M.p. 174–176°. IR (KBr): 2197s, 2189s,
1639m, 1591w, 1509s, 1486s, 1406w, 1360m, 1264m, 1185w, 1089m, 1021w, 1013w, 863w,
849w, 809w, 721w, 616w. 1H-NMR: 1.80 (s, Me); 6.75 (s, HC(5’)); 7.23, 7.52 (AA’BB’, JAB =
11
8.2, 4 arom. H). 13C-NMR: 16.8 (Me); 48.4 (C(CN)2); 103.0 (C(5’)); 112.5, 118.4 (2 CN);
130.0 (2 arom. CH); 130.5 (2 arom. CH); 134.4 (C(4’)); 137.8, 140.8 (2 arom. C); 174.0
(C(2’)). CI-MS (NH3): 342 (7), 341 (43), 340 (15), 339 (100, [M(
80Se)+NH4]
+), 338 (11), 337
(48), 336 (16), 335 (17). Anal. calc. for C13H8N3SeCl (320.64): C 48.70, H 2.51, N 13.11;
found: C 48.69, H 2.67, N 13.13.
2-[2,3-Dihydro-3-(4-bromophenyl)-4-methyl-1,3-selenazol-2-ylidene]malononitrile
(12d). Yield: 152.6 mg (38%). Yellowish crystals. M.p. 187–189°. IR (KBr): 2199s, 2183s,
1637w, 1606w, 15012s, 1481s, 1400m, 1347m, 1268m, 1070m, 1012m, 880w, 842m, 805w,
756 w, 716w, 613w. 1H-NMR: 1.79 (s, Me); 6.75 (s, HC(5’)); 7.15, 7.66 (AA’BB’, JAB = 8.7, 4
arom. H). 13C-NMR: 16.9 (Me); 48.5 (C(CN)2); 103.2 (C(5’)); 112.6, 118.5 (2 CN); 125.8 (1
arom. C); 130.2 (2 arom. CH); 132.6 (C(4’)); 133.5 (2 arom. CH); 134.5, 140.8 (2 arom. C);
173.9 (C(2’)). CI-MS (i-butane): 370 (12), 369 (12), 368 (77), 367 (22), 366 (100,
[M(80Se,78Br)+1]+), 365 (27), 364 (48), 363 (17), 362 (15). Anal. calc. for C13H8N3SeBr
(365.10): C 42.77, H 2.21, N 11.51; found: C 42.60, H 2.05, N 11.50.
2-[2,3-Dihydro-4-methyl-3-(4-methylphenyl)-1,3-selenazol-2-ylidene)malononitrile
(12e). Yield: 184.9 mg (56%). Yellowish crystals. M.p. 135–137°. IR (KBr): 3251w, 2202s,
2192s, 1639m, 1586w, 1509s, 1362m, 1267m, 1109w, 1024w, 1013w, 852w, 809w, 772w,
712w, 619w. 1H-NMR: 2.08, 2.53 (2s, 2 Me); 6.80 (s, HC(5’)); 7.35, 7.48 (AA’BB’, JAB = 8.2,
4 arom. H). 13C-NMR: 20.8, 27.2 (2 Me); 50.1 (C(CN)2); 95.4 (C(5’)); 111.4, 117.5 (2 CN);
128.5 (2 arom. CH); 129.4 (C(4’)); 130.4 (2 arom. CH); 140.4, 151.9 (2 arom. C); 173.2
(C(2’)). CI-MS (NH3): 322 (5), 321 (44), 320 (22), 319 (100, [M(
80Se)+NH4]
+), 318 (19), 317
(54), 316 (12), 315 (18). Anal. calc. for C14H11N3Se (300.22): C 56.01, H 3.69, N 14.00;
found: C 56.07, H 3.65, N 13.78.
12
2-(2,3-Dihydro-4-methyl-3-phenyl-1,3-selenazol-2-ylidene)-3-oxo-3-phenyl-
propionitrile (12f). Yield: 200.9 mg (50%). Yellowish crystals. M.p. 197–199°C. IR (KBr):
3089w, 2918w, 2192s, 1590m, 1566m, 1491m, 1445m, 1430s, 1332s, 1310m, 1272w, 1212w,
1175w, 1154w, 1107w, 1071w, 1018w, 956w, 858m, 794w, 775w, 721m, 697m, 670m. 1H-
NMR: 1.95 (s, Me); 7.02 (s, HC(5’)); 7.31–7.42 (m, 5 arom. H); 7.55–7.65 (m, 3 arom. H);
7.74 (d-like, J = 8.2, 2 arom. H). 13C-NMR: 16.9 (Me); 60.3 (C(CN)); 109.8 (C(5’)); 117.5
(CN); 127.7 (2 arom. CH); 128.1 (2 arom. CH); 128.7 (2 arom. CH); 129.8 (2 arom. CH);
130.6, 130.9 (2 arom. CH); 138.1, 138.5, 139.2 (C(4’), 2 arom. C); 171.4 (C(2’)); 187.7 (CO).
CI-MS (i-butane): 369 (20), 368 (22), 367 (100, [M(80Se)+1]+), 366 (12), 365 (51), 364 (20),
363 (19). Anal. calc. for C19H14N2OSe (365.29): C 62.47, H 3.86, N 7.67; found: C 62.45, H
3.79, N 7.51.
2-{[(4-Methoxyphenyl)amino][(prop-2-ynyl)selanyl]methylene}malononitrile (9b).
Yield: 156.5 mg (45%). Yellowish crystals. M.p. 133–135°. IR (KBr): 3256m (br), 2211s,
2195s, 1607m, 1518s, 1509s, 1440w, 1414w, 1299w, 1252m, 1190w, 1107w, 1031w, 946w,
837w, 718w, 686w, 636w, 607w. 1H-NMR: 2.59 (t, J = 2.7, ≡CH); 3.64 (d, J =2.7, CH2); 4.03
(s, MeO); 7.12, 7.38 (AA’BB’, JAB = 8.1, 4 arom. H); 8.48 (br. s, NH). 
13C-NMR: 14.4 (CH2);
55.5 (MeO); 59.8 (C(CN)2); 74.2 (≡CH); 77.7 (C≡CH); 113.8 (CN); 114.6 (2 arom. CH);
115.3 (CN); 126.9 (2 arom. CH); 130.0, 159.4 (2 arom. C); 166.9 (NCSe). CI-MS (i-butane):
320 (18), 319 (17), 318 (100, [M(80Se)+1]+), 317 (19), 316 (51), 315 (25), 314 (22). Anal.
calc. for C14H11N3OSe (316.22): C 53.18, H 3.51, N 13.29; found: C 53.31, H 3.68, N 13.20.
2-{[(4-Methylphenyl)amino][(prop-2-ynyl)selanyl]methylene}malononitrile (9e). Yield:
79.3 mg (24%). Yellowish crystals. M.p. 154–156°. IR (KBr): 3256s, 3218s, 2974w, 2213s,
2198s, 1586m, 1518s, 1507s, 1419w, 1404w, 1307w, 1291w, 1266w, 1190w, 1108w, 1015w,
951w, 821m, 713m, 688m, 637w, 606m. 1H-NMR: 2.36 (s, Me); 2.42 (t, J = 2.7, ≡CH); 3.53
13
(d, J = 2.7, CH2); 7.14–7.21 (m, 4 arom. H); 10.08 (br. s, NH). 
13C-NMR: 14.0 (Me); 20.9
(CH2): 58.6 (C(CN)2); 73.8 (≡CH); 78.0 (C≡CH); 113.8, 116.3 (2 CN); 124.4 (2 arom. CH);
129.7 (1 arom. C); 130.6 (2 arom. CH); 135.8 (1 arom. C); 165.6 (NCSe). CI-MS (NH3): 321
(18), 320 (17), 319 (100, [M(80Se)+NH4]
+), 318 (19), 317 (51), 316 (25), 315 (22). Anal. calc.
for C14H11N3Se (300.22): C 56.01, H 3.69, N 14.00; found: C 55.89, H 3.55, N 13.90.
Suitable crystals for the X-ray crystal structure determination were grown from CH2Cl2
by slow evaporation of the solvent.
X-Ray Crystal-Structure Determination of 9e and 11a (see Table 2 and Figs. 1 and 2)2).
All measurements were made on a Nonius KappaCCD diffractometer [35] using graphite-
monochromated MoKα radiation (λ 0.71073 Å) and an Oxford Cryosystems Cryostream 700
cooler. Data reduction was performed with HKL Denzo and Scalepack [36]. The intensities
were corrected for Lorentz and polarization effects, and absorption corrections based on the
multi-scan method [37] were applied. Equivalent reflections were merged. The data collection
and refinement parameters are given in the Table, and views of the molecules are shown in
the Figs 1 and 2. The structures were solved by direct methods using SIR92 [38] in the case of
9e and SHELXS97 in the case of 11a, which revealed the positions of all non-H-atoms. The
non-H-atoms were refined anisotropically. The molecule of 11a sits across a crystallographic
mirror plane, but the heterocyclic ring and terminal methylene groups do not lie in the plane,
so are necessarily disordered across the mirror. The Ph ring lies perpendicular to the mirror
                                                           
2) CCDC-665411 and 665412 contain the supplementary crystallographic data for this paper.
These data can be obtained free of charge from the Cambridge Crystallographic Data Centre
via http://www.ccdc.ac.uk/data_request/cif.
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plane and is also tilted so that the ipso and para C-atoms do not lie on the mirror, which
results in the entire phenyl ring being disordered about the mirror plane as well. In reality, the
ipso C-atom, C(9), must lie slightly off the mirror plane if the phenyl group is disordered in
this way, but the refinement became unstable if C(9) was forced to remain off the mirror.  The
final model has C(9) on the mirror plane, which leads to a slight distortion of the proper
geometry of the Ph ring.  Neighboring atoms within and between each conformation of the
disordered Ph group were restrained to have similar atomic displacement parameters. The
amine H-atom of 9e and the H-atoms of the terminal methylene group of 11a were placed in
the positions indicated by a difference electron density map and their positions were allowed
to refine.  All remaining H-atoms were placed in geometrically calculated positions and
refined using a riding model, where each H-atom was assigned a fixed isotropic displacement
parameter with a value equal to 1.2Ueq of its parent atom (1.5Ueq for the Me group of 9e). The
refinement of each structure was carried out on F2 using full-matrix least-squares procedures,
which minimized the function Σw(Fo
2–Fc
2)2.  A correction for secondary extinction was
applied in the case of 9e. For 11a, one reflection, whose intensity was considered to be an
extreme outlier, was omitted from the final refinement. Neutral atom scattering factors for
non-H-atoms were taken from [40a], and the scattering factors for H-atoms were taken from
[41].  Anomalous dispersion effects were included in Fc [42]; the values for ƒ’ and ƒ” were
those of [40b]. The values of the mass attenuation coefficients are those of [40c]. All
calculations were performed using the SHELXL97 [43] program.
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Table 1. Preparation of Selenazole Derivatives 12 from Isoselenocyanates 1
Entry R 12 M.p. [°] Yield
[%]
Intermediate 9 M.p. [°] Yield
[%]
a Ph
NC CN
N Se
Me
235–237 50
b 4-MeOC6H4
NC CN
N Se
MeO
Me
247–249 45
NC CN
SeHN
OMe
133–135 28
c 4-ClC6H4
NC CN
N Se
Cl
Me
174–176 45
d 4-BrC6H4 187–189 38
e 4-MeC6H4
NC CN
N Se
Me
Me
135–137 56
NC CN
SeHN
CH3
154–156 24
f Ph NC
N Se
Me
O
197–199 50
NC CN
N Se
Br
Me
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Table 2.  Crystallographic Data for Compounds 9e and 11a
9e 11a
____________________________________________________________________________
Crystallized from CH2Cl2 AcOEt
Empirical formula C14H11N3Se C13H9N3Se
Formula weight 300.16 286.13
Crystal color, habit pale-orange, prism colorless, plate
Crystal dimensions [mm] 0.20 × 0.25 × 0.45 0.02 × 0.22 × 0.27
Temperature [K] 160(1) 273(1)
Crystal system monoclinic monoclinic
Space group P21/c P21/m
Z 4 2
Reflections for cell determination 22421 38309
2θ range for cell determination [°] 4–60 4–60
Unit cell parameters a [Å] 11.2096(2) 8.5520(2)
b [Å] 15.8370(3) 7.4215(2)
c [Å] 7.4753(1) 10.3021(3)
β [°] 94.561(1) 107.579(2)
V [Å
3
] 1322.86(4) 623.33(3)
Dx [g cm
-3
] 1.507 1.524
µ(MoKα) [mm
-1
] 2.822 2.990
Scan type φ and ω ω
2θ(max) [°] 60 60
Transmission factors [min; max] 0.484; 0.580 0.660; 0.945
Total reflections measured 35475 17600
Symmetry independent reflections 3880 1936
Reflections with I>2σ(I) 3429 1565
Reflections used in refinement 3880 1935
Parameters refined; restraints 169; 0 130; 36
Final R(F)  [I>2σ (I) reflections] 0.0263 0.0304
wR(F
2
)  (all data) 0.0680 0.0676
Weighting parameters [a; b]a) 0.0331; 0.6712 0.0258; 0.1683
Goodness of fit 1.052 1.073
Secondary extinction coefficient 0.0051(8) -
Final Δmax/σ 0.001 0.001
Δρ (max; min) [e Å
-3
] 0.48; –0.71 0.27; –0.38
a) w-1 = σ 2(Fo
2) + (aP)2 + bP  where P = (Fo
2 + 2Fc
2)/3
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